XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsrxi-completes-enrolment-in-second-phase-i-trial-of-anti-scarring-drug/20%Daily2013-01-31 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsdaiichi-sankyo-arqule-enrol-first-patient-in-hepatocellular-carcinoma-drug-trial/20%Daily2013-01-31 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsanacor-reports-positive-preliminary-results-from-tavaborole-phase-iii-onychomycosis-trial/20%Daily2013-01-30 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsfda-approves-kynamro-injection-for-homozygous-familial-hypercholesterolemia/20%Daily2013-01-30 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsidenix-janssen-collaborate-to-develop-hcv-combination-therapies/20%Daily2013-01-29 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsacceleron-commences-phase-ii-myelodysplastic-syndromes-study-of-ace-536/20%Daily2013-01-29 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsamgen-reports-positive-results-from-phase-iii-colorectal-cancer-study/20%Daily2013-01-28 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsalgeta-to-evaluate-targeted-thorium-conjugate-for-cancer-therapy/20%Daily2013-01-28 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsibm-the-institute-of-bioengineering-and-nanotechnology-jointly-develop-antimicrobial-hydrogel/20%Daily2013-01-27 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsmerck-serono-commences-phase-iii-pancreatic-adenocarcinoma-study-of-th-302/20%Daily2013-01-27 18:30
https://www.clinicaltrialsarena.com/uncategorized/newscellmid-reports-positive-data-from-diabetic-nephropathy-study-with-anti-midkine-antibodies/20%Daily2013-01-24 18:30
https://www.clinicaltrialsarena.com/marketdata/featurestraight-to-the-source-targeted-pain-relief/20%Daily2019-08-09 11:43
https://www.clinicaltrialsarena.com/uncategorized/newsgilead-commences-phase-iii-study-of-tenofovir-alafenamide-to-treat-hiv/20%Daily2013-01-24 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsnymox-reports-positive-results-from-phase-iii-benign-prostatic-hyperplasia-study-of-nx-1207/20%Daily2013-01-23 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsvistagen-concludes-final-phase-i-study-of-av-101-pain-prodrug/20%Daily2013-01-23 18:30
https://www.clinicaltrialsarena.com/uncategorized/newssynthon-reports-positive-pre-clinical-results-from-her2-antibody-drug-conjugate-studies/20%Daily2013-01-22 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsemergent-initiates-phase-ii-biothrax-study-to-support-post-exposure-prophylaxis-indication/20%Daily2013-01-22 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsfda-clears-allergans-botox-for-treatment-of-overactive-bladder/20%Daily2013-01-21 18:30
https://www.clinicaltrialsarena.com/uncategorized/newscsl-behring-commences-patient-enrolment-in-paediatric-phase-iii-haemophilia-b-study/20%Daily2013-01-21 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsglycomimetics-completes-enrolment-in-gmi-1070-phase-ii-sickle-cell-disease-study/20%Daily2013-01-20 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsaxelar-commences-axl1717-phase-iii-brain-tumour-study-in-us/20%Daily2013-01-20 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsamgen-phase-3-aranesp-red-hf-trial-fails-to-meet-primary-endpoint/20%Daily2013-01-17 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsemergent-commences-dosing-phase-2-trial-nuthrax-anthrax-vaccine/20%Daily2013-01-17 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsdmu-develops-new-drug-development-technology/20%Daily2013-01-16 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsstealth-peptides-commences-phase-2-study-bendavia/20%Daily2013-01-16 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsscottish-medicines-consortium-issues-guidance-for-forxiga/20%Daily2013-01-15 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsc-disease-specific-pluripotent-stem-cell-lines/20%Daily2013-01-15 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsec-clears-extended-licence-to-janssenzytiga/20%Daily2013-01-14 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsreviva-completes-enrolment-phase-2-rp5063/20%Daily2013-01-14 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsmorphotek-phase-iii-study-of-farletuzumab-fails-to-meet-primary-endpoint/20%Daily2013-01-13 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsdaiichi-sankyo-arqule-phase-ii-study-of-tivantinib-fails-to-meet-primary-endpoint/20%Daily2013-01-13 18:30
https://www.clinicaltrialsarena.com/uncategorized/newstapimmune-reports-positive-interim-safety-analysis-in-breast-cancer-study/20%Daily2013-01-10 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsnew-research-finds-spin-bias-in-published-breast-cancer-studies/20%Daily2013-01-10 18:30
https://www.clinicaltrialsarena.com/uncategorized/newssantaris-mirage-expand-microrna-therapeutic-research-deal/20%Daily2013-01-09 18:30
https://www.clinicaltrialsarena.com/uncategorized/newscoda-reports-positive-data-from-phase-iib-study-of-nexagon/20%Daily2013-01-09 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsboehringer-eli-lilly-report-positive-data-from-empagliflozin-phase-iii-trials/20%Daily2013-01-08 18:30
https://www.clinicaltrialsarena.com/uncategorized/newstg-therapeutics-commences-tgr-1202-phase-i-trial/20%Daily2013-01-08 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsedison-commences-epi-743-phase-iib-friedreichs-ataxia-trial/20%Daily2022-03-21 08:33
https://www.clinicaltrialsarena.com/uncategorized/newsdaiichi-amplimmune-sign-autoimmune-disease-research-partnership/20%Daily2013-01-07 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsbayer-onyx-report-positive-results-from-thyroid-cancer-trial-of-nexavar/20%Daily2013-01-06 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsproteon-reports-positive-data-from-phase-ii-trial-of-prt-201/20%Daily2013-01-06 18:30
https://www.clinicaltrialsarena.com/uncategorized/newssynergy-reports-positive-results-from-phase-iibiii-chronic-idiopathic-constipation-trial/20%Daily2013-01-03 18:30
https://www.clinicaltrialsarena.com/uncategorized/newscerulean-commences-phase-ii-gastric-cancer-study-of-crlx101/20%Daily2013-01-03 18:30
https://www.clinicaltrialsarena.com/marketdata/featurepermeable-pathway-next-generation-transdermal-drug-delivery/20%Daily2013-01-02 23:30
https://www.clinicaltrialsarena.com/uncategorized/newsevotec-apeiron-sign-cancer-immunotherapy-research-partnership/20%Daily2013-01-02 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsastex-commences-phase-ii-liver-cancer-trial-of-sgi-110/20%Daily2013-01-02 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsproteome-reports-positive-results-from-ck1d-inhibitor-in-vivo-study/20%Daily2013-01-01 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsfda-approves-janssen-pulmonary-multi-drug-resistant-tuberculosis-therapy/20%Daily2013-01-01 18:30